169 related articles for article (PubMed ID: 16931909)
1. Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease.
Laufs S; Schumacher J; Allgayer H
Cell Cycle; 2006 Aug; 5(16):1760-71. PubMed ID: 16931909
[TBL] [Abstract][Full Text] [Related]
2. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
Allgayer H; Aguirre-Ghiso JA
APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
4. Regulation and clinical significance of urokinase-receptor (u-PAR), an invasion-related molecule.
Allgayer H
Z Gastroenterol; 2006 Jun; 44(6):503-11. PubMed ID: 16773517
[TBL] [Abstract][Full Text] [Related]
5. Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy.
Allgayer H
Recent Results Cancer Res; 2003; 162():15-30. PubMed ID: 12790318
[TBL] [Abstract][Full Text] [Related]
6. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the urokinase receptor (u-PAR)--a central molecule of invasion and metastasis.
Fuchs T; Allgayer H
Biol Chem; 2003 May; 384(5):755-61. PubMed ID: 12817472
[TBL] [Abstract][Full Text] [Related]
8. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
9. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
10. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers.
Schewe DM; Leupold JH; Boyd DD; Lengyel ER; Wang H; Gruetzner KU; Schildberg FW; Jauch KW; Allgayer H
Clin Cancer Res; 2003 Jun; 9(6):2267-76. PubMed ID: 12796395
[TBL] [Abstract][Full Text] [Related]
12. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.
Ciavarella S; Laurenzana A; De Summa S; Pilato B; Chillà A; Lacalamita R; Minoia C; Margheri F; Iacobazzi A; Rana A; Merchionne F; Fibbi G; Del Rosso M; Guarini A; Tommasi S; Serratì S
BMC Cancer; 2017 Mar; 17(1):215. PubMed ID: 28340565
[TBL] [Abstract][Full Text] [Related]
13. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.
Sier CF; Quax PH; Vloedgraven HJ; Verheijen JH; Griffioen G; Ganesh S; Lamers CB; Verspaget HW
Invasion Metastasis; 1993; 13(6):277-88. PubMed ID: 7860221
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-type plasminogen activator system in cancer metastasis: a review.
Andreasen PA; Kjøller L; Christensen L; Duffy MJ
Int J Cancer; 1997 Jul; 72(1):1-22. PubMed ID: 9212216
[TBL] [Abstract][Full Text] [Related]
20. Translational research on u-PAR.
Allgayer H
Eur J Cancer; 2010 May; 46(7):1241-51. PubMed ID: 20362429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
